Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis

View at publisher
Authors: Radha Devi, Pyush Dadwal, Nitin Sharma, Amandeep Singh, Akshita Arora
Cited by: 1
References: 76

Fields of Study & Subjects

Advances in Cucurbitaceae Research Natural Antidiabetic Agents Studies Curcumin's Biomedical Applications

Publication details

Journal / source
Inflammopharmacology
Publisher
Springer Science and Business Media LLC
Volume
34
Issue
7
Pages
4463–4481
Publication date
15 June 2026
Language
EN